S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7121 +0.17%
AFTER HRS · 17:05 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

ABBV

AbbVie Inc.
NYSE · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
284.80
−4.28 −1.48%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $503.3BP/E 80.5DIV YIELD 2.40%FCF YIELD 3.62%REV TTM $64.4B +10.4%NET INCOME $6.3B +67.7%NET DEBT $57.9B52W 197.38 – 289.08SEC XBRL · TTM TO Invalid Date

What ABBV had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Oct 15Officer or director changeOct 14open on EDGAR ↗
Oct 5Results announcedOct 5open on EDGAR ↗
Sep 3Reg FD disclosureSep 3open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch ABBV. Know when insiders buy.
One email the day a filing lands. Free.